Local Government Announces Cost and Safety Benefits of First i.v.STATION Robot at University Hospital in African Continent
BOZEN, Sud-Tirol, Italy, May 8, 2013 /PRNewswire/ --
Health Robotics' i.v.STATION Robot continued on its undeterred path to collect endorsements and customer testimonials from pharmacists all over the world, documenting its unprecedented cost savings and patient safety benefits.
The Government of Canary Islands' Health Counsel stated in its official press release last week: "With the implementation of the i.v.STATION Robot, the Pharmacy Department at University Hospital of Gran Canaria Doctor Negrin assures the correct preparation of injectable medications for patient administration with the maximum guarantees of safety, by minimizing dose errors, cross contamination, and hospital-acquired infections, while protecting clinical staff. In addition, the i.v.STATION Robot saves costs and reduces turnaround time, benefiting the patients while optimizing pharmacy staffing levels." http://www2.gobiernodecanarias.org/sanidad/noticiashow.aspx?id=153341
Gaspar DeViedma, Health Robotics' Executive Vice President and Board Member, stated: "Health Robotics' first installation in the African continent is yet another example that the i.v.STATION Robot has gone mainstream with consistent cost savings and safety benefits for global hospitals. Reaching 175 Robot installations and an overwhelming 90% market share, Health Robotics now has approximately 10 times more Robot installations than all of its worldwide competitors combined http://www.health-robotics.com/en/compare-products/, in North America, Europe, Asia, South America, Australia, and now also in Africa."
The Government of Canary Islands Health Counsel continued: "The i.v.STATION Robot prepares liquid and powder medications in syringes and IV Bags for biologic, antifungal, intravitreous, and antibiotic drugs, which where formerly prepared in laminar airflow hoods in the Pharmacy, or the case of antibiotics at some of the wards or nurse stations throughout the hospital. The i.v.STATION Robot security features include the automatic verification of each ingredient's weight, the automatic bar-code labeling of final containers, and complete audit trail of the compounding process. This improves the guarantees on sterility, conservation, and extended expiration date, due to i.v.STATION's air quality and ultraviolet sterilization chamber. Finally i.v.STATION has the extra cost saving benefits of re-using vials, which optimizes the cost of expensive drugs, and the reduced labor costs associated with clinical staff injuries due to needle-stick and repetitive strain."
About Health Robotics:
Founded in 2006 and now reaching 80% total IV Robots market share in the world [including over 90% the Oncology Robots global market], Health Robotics is the undisputed leading supplier of life-critical intravenous medication robots, providing over 350 hospital installations in 6 continents with the only fully-integrated robotics-based technology, IV Workflow, and manual compounding software automation solution. Health Robotics' second generation products [i.v.STATION, i.v.SOFT, and i.v.STATION ONCO] have been found [through scientific and peer-reviewed studies,] to greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput, and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' medical devices and integrated workflow solutions help hospitals eliminate life-threatening drug and diluent exchange errors, improve drug potency, decrease other medical mistakes and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce nursing, and pharmacy staff. For more information, please visit: http://www.health-robotics.com
1. Ten Global Competitors: Intelligent Hospital Systems/RIVA, Fresenius Kabi/MDS, Baxter/Baxa, Loccioni, Kiro, Panasonic, Yuyama, Yasukawa, Integra, and Pharmaduct
2. Impact of Robotic Antineoplastic Preparation on Safety, Workflow, Costs. Seger, Churchill, Keohane, Belisle, Wong, Sylvester, Chesnick, Burdick, Wien, Cotugno, Bates, and Rothschild. Brigham & Women's Hospital, Massachusetts College of Pharmacy, and Harvard Medical School. Journal of Oncology Practice, Nov. 2012, Volume 8, number 6.
3. Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin®, Remicade®, and Herceptin®. Peters, Capelle, Arvinte, van de Garde. St. Antonius Hospital. mAbs January 2013, Volume 5, Issue 1.
For additional information, please contact:
SOURCE Health Robotics
More by this Source
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.